Bank of Montreal’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-263
Closed -$17.9K 3868
2022
Q4
$17.9K Hold
263
﹤0.01% 3712
2022
Q3
$33 Hold
263
﹤0.01% 3714
2022
Q2
$28 Hold
263
﹤0.01% 3715
2022
Q1
$44K Buy
+263
New +$51.2K ﹤0.01% 3808

Other funds holding DNA

Bank of Montreal's DNA Position: Q1 2024 in Review

Bank of Montreal sold out of Ginkgo Bioworks (DNA) in Q1 2024, closing a stake of 308 shares — an estimated $21.9K sold.

Bank of Montreal first reported a position in DNA in Q4 2021 and held it in 9 quarters. The position peaked at $214K in Q4 2021. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Bank of Montreal reported no remaining Ginkgo Bioworks position as of Q1 2024 after selling out during the quarter.
  • Bank of Montreal sold 308 Ginkgo Bioworks shares in Q1 2024, an estimated $21.9K.
  • Bank of Montreal first reported a position in Ginkgo Bioworks in Q4 2021 and held it in 9 quarters.
  • Bank of Montreal's Ginkgo Bioworks position peaked at $214K in Q4 2021.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Bank of Montreal's 13F filing for Q1 2024, filed 13 May 2024.